Does BENDAMUSTINE Cause Progressive multifocal leukoencephalopathy? 342 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 342 reports of Progressive multifocal leukoencephalopathy have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 1.7% of all adverse event reports for BENDAMUSTINE.
342
Reports of Progressive multifocal leukoencephalopathy with BENDAMUSTINE
1.7%
of all BENDAMUSTINE reports
172
Deaths
140
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From BENDAMUSTINE?
Of the 342 reports, 172 (50.3%) resulted in death, 140 (40.9%) required hospitalization, and 42 (12.3%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for BENDAMUSTINE.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which BENDAMUSTINE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE